GCP
LLY icon

GSA Capital Partners’s Eli Lilly LLY Stock Holding History

GSA Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
1,713
+740
+76% +$750K 0.1% 255
2025
Q4 		$1.05M Sell
973
-319
-25% -$305K 0.09% 336
2025
Q3 		$986K Sell
1,292
-2,096
-62% -$1.56M 0.08% 407
2025
Q2 		$2.64M Buy
+3,388
New +$2.63M 0.19% 63
2025
Q1 		– Sell
-2,066
Closed -$1.59M – 1895
2024
Q4 		$1.59M Buy
2,066
+1,382
+202% +$1.14M 0.12% 157
2024
Q3 		$606K Buy
+684
New +$615K 0.05% 798
2023
Q4 		– Sell
-5,044
Closed -$2.71M – 1737
2023
Q3 		$2.71M Buy
5,044
+3,351
+198% +$1.73M 0.23% 43
2023
Q2 		$794K Buy
+1,693
New +$710K 0.08% 443
2023
Q1 		– Sell
-723
Closed -$265K – 1729
2022
Q4 		$265K Buy
+723
New +$256K 0.03% 1017
2022
Q3 		– Sell
-3,069
Closed -$995K – 1724
2022
Q2 		$995K Sell
3,069
-2,914
-49% -$875K 0.15% 148
2022
Q1 		$1.71M Buy
5,983
+4,515
+308% +$1.16M 0.23% 49
2021
Q4 		$405K Sell
1,468
-514
-26% -$130K 0.05% 736
2021
Q3 		$458K Buy
+1,982
New +$489K 0.05% 749
2021
Q1 		– Sell
-1,221
Closed -$206K – 1304
2020
Q4 		$206K Sell
1,221
-1,787
-59% -$267K 0.03% 969
2020
Q3 		$445K Buy
+3,008
New +$466K 0.07% 467
2020
Q1 		– Sell
-2,400
Closed -$315K – 1328
2019
Q4 		$315K Sell
2,400
-2,332
-49% -$270K 0.04% 986
2019
Q3 		$529K Sell
4,732
-10,811
-70% -$1.2M 0.07% 517
2019
Q2 		$1.72M Buy
15,543
+6,734
+76% +$793K 0.19% 68
2019
Q1 		$1.14M Sell
8,809
-532
-6% -$64.7K 0.12% 236
2018
Q4 		$1.08M Sell
9,341
-1,159
-11% -$129K 0.12% 184
2018
Q3 		$1.13M Buy
+10,500
New +$1.05M 0.06% 605
2016
Q4 		– Sell
-16,896
Closed -$1.36M – 1872
2016
Q3 		$1.36M Sell
16,896
-12,276
-42% -$983K 0.07% 434
2016
Q2 		$2.3M Sell
29,172
-4,605
-14% -$347K 0.13% 180
2016
Q1 		$2.43M Sell
33,777
-63,358
-65% -$4.79M 0.16% 123
2015
Q4 		$8.19M Buy
97,135
+72,052
+287% +$5.98M 0.4% 7
2015
Q3 		$2.1M Sell
25,083
-15,017
-37% -$1.27M 0.1% 239
2015
Q2 		$3.35M Sell
40,100
-4,818
-11% -$367K 0.13% 140
2015
Q1 		$3.26M Sell
44,918
-17,519
-28% -$1.25M 0.13% 128
2014
Q4 		$4.31M Buy
62,437
+2,251
+4% +$152K 0.3% 18
2014
Q3 		$3.9M Buy
+60,186
New +$3.81M 0.21% 88
2014
Q2 		– Sell
-14,605
Closed -$860K – 1892
2014
Q1 		$860K Sell
14,605
-33,405
-70% -$1.86M 0.06% 424
2013
Q4 		$2.45M Sell
48,010
-103,798
-68% -$5.2M 0.19% 72
2013
Q3 		$7.64M Buy
151,808
+57,524
+61% +$3.01M 0.6% 5
2013
Q2 		$4.63M Buy
+94,284
New +$5.13M 0.55% 10

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GSA Capital Partners's LLY Position: Q1 2026 in Review

GSA Capital Partners increased its Eli Lilly (LLY) stake by 76% in Q1 2026, buying an estimated $750K and bringing the position to 1,713 shares worth $1.58M. The position accounts for 0.1% of the portfolio, ranked #255.

GSA Capital Partners first reported a position in LLY in Q2 2013 and has held it in 34 quarters since. The position peaked at $8.19M in Q4 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GSA Capital Partners held 1,713 shares of Eli Lilly worth $1.58M as of Q1 2026.
  • GSA Capital Partners bought 740 Eli Lilly shares in Q1 2026, an estimated $750K.
  • Eli Lilly made up 0.1% of GSA Capital Partners's portfolio in Q1 2026, its #255 holding.
  • GSA Capital Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 34 quarters since.
  • GSA Capital Partners's Eli Lilly position peaked at $8.19M in Q4 2015.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.